CCA
CDLX icon

Covey Capital Advisors’s Cardlytics CDLX Stock Holding History

Covey Capital Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-998
Closed -$223K – 32
2022
Q2 		$223K Sell
998
-1,209
-55% -$405K 0.33% 33
2022
Q1 		$1.21M Sell
2,207
-161
-7% -$97.3K 1.26% 22
2021
Q4 		$1.56M Sell
2,368
-1,059
-31% -$810K 1.26% 23
2021
Q3 		$2.88M Buy
+3,427
New +$3.48M 2.3% 16
2021
Q2 		– Sell
-3,957
Closed -$4.47M – 14
2021
Q1 		$4.34M Sell
3,957
-817
-17% -$1.08M 3.6% 15
2020
Q4 		$6.82M Sell
4,774
-485
-9% -$517K 5.95% 5
2020
Q3 		$3.71M Sell
5,259
-1,263
-19% -$918K 3.88% 11
2020
Q2 		$4.56M Sell
6,522
-1,126
-15% -$650K 5.74% 6
2020
Q1 		$2.67M Sell
7,648
-647
-8% -$458K 4.53% 9
2019
Q4 		$5.21M Buy
8,295
+2,362
+40% +$1.15M 5.63% 7
2019
Q3 		$1.99M Buy
+5,933
New +$1.9M 2.36% 19

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Covey Capital Advisors's CDLX Position: Q3 2022 in Review

Covey Capital Advisors sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 998 shares — an estimated $223K sold.

Covey Capital Advisors first reported a position in CDLX in Q3 2019 and held it in 11 quarters. The position peaked at $6.82M in Q4 2020. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Covey Capital Advisors reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Covey Capital Advisors sold 998 Cardlytics shares in Q3 2022, an estimated $223K.
  • Covey Capital Advisors first reported a position in Cardlytics in Q3 2019 and held it in 11 quarters.
  • Covey Capital Advisors's Cardlytics position peaked at $6.82M in Q4 2020.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Covey Capital Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.